The Use of Bioinformatics in the Identification of Novel Therapeutic Targets
American Journal of Bioinformatics · 30.04.2025 · 6 (2) · 12-16
DOI: 10.71465/ajb.2724 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Bioinformatics, online erschienen am 30.04.2025. Verfasst von Dr. Peter Johnson. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The identification of novel therapeutic targets is a crucial step in the development of new treatments for a wide range of diseases. Bioinformatics has become a powerful tool in the discovery and validation of potential drug targets by analyzing vast amounts of genomic, transcriptomic, and proteomic data. This article discusses the role of bioinformatics in the identification of therapeutic targets, including the use of omics data analysis, functional annotation, network-based approaches, and predictive modeling. We also explore the challenges and future directions in this field and highlight the importance of bioinformatics in advancing personalized medicine
Zitieren
APA
Johnson, D. P. (2025). The Use of Bioinformatics in the Identification of Novel Therapeutic Targets. American Journal of Bioinformatics, 6(2), 12-16. https://doi.org/10.71465/ajb.2724
Vancouver
Johnson DP. The Use of Bioinformatics in the Identification of Novel Therapeutic Targets. American Journal of Bioinformatics. 2025;6(2):12-16. doi:10.71465/ajb.2724
BibTeX
@article{Johnson2025,
author = {Johnson, Dr. Peter},
title = {The Use of Bioinformatics in the Identification of Novel Therapeutic Targets},
journal = {American Journal of Bioinformatics},
year = {2025},
volume = {6},
number = {2},
pages = {12--16},
doi = {10.71465/ajb.2724}
}
EUVIMED